Search Within

Natasha Rekhtman

  1. "Achim Jungbluth"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (13)
Groups
  1. Department of Pathology and Laboratory Medicine (30)
  2. Department of Medicine (20)
  3. GSK Faculty (19)
  4. Solid Tumor Oncology Division (19)
  5. Thoracic Oncology (18)
  6. Human Oncology and Pathogenesis Program (13)

More Groups

People
  1. Achim Jungbluth (30)
  2. William Travis (16)
  3. Jason Chang (15)
  4. Jennifer Sauter (14)
  5. Denise Frosina (12)
  6. Marc Ladanyi (12)

More People

Years
  1. 2024 (2)
  2. 2023 (1)
  3. 2022 (3)
  4. 2021 (8)
  5. 2020 (7)
  6. 2019 (1)

More Years

Publications
  1. Laboratory Investigation (9)
  2. Modern Pathology (7)
  3. Journal of Thoracic Oncology (4)
  4. Cancer Cytopathology (2)
  5. American Journal of Surgical Pathology (1)
  6. Applied Immunohistochemistry & Molecular Morphology (1)

More Publications

Publishers
  1. Nature Publishing Group (9)
  2. Nature Research (7)
  3. Elsevier Inc. (5)
  4. American Society of Clinical Oncology (2)
  5. John Wiley & Sons (2)
  6. Lippincott Williams & Wilkins (2)

More Publishers

Results (30)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen–targeted therapies
    Journal Article

    Zaidi, S.; Park, J.; Chan, J. M.; Roudier, M. P.; Zhao, J. L.; Gopalan, A.; Wadosky, K. M.; Patel, R. A.; Sayar, E.; Karthaus, W. R.; more...
    Proceedings of the National Academy of Sciences of the United States of America (2024)

    Fulltext@MSK | Save
  • Comparison of immunohistochemistry, next-generation sequencing and fluorescence in situ hybridization for detection of MTAP loss in pleural mesothelioma
    Journal Article

    Febres-Aldana, C. A.; Chang, J. C.; Jungbluth, A. A.; Adusumilli, P. S.; Bodd, F. M.; Frosina, D.; Geronimo, J. A.; Hernandez, E.; Irawan, H.; Offin, M. D.; more...
    Modern Pathology (2024)

    Fulltext@MSK | Save
  • "Hepatoid" Lung carcinoma demystified: HepPar1/CPS1 expression in carcinomas with solid and granular morphology reflects high mitochondrial content and metabolic reprogramming accompanying STK11/KEAP1/SMARCA4 alterations and is unrelated to hepatocellular differentiation
    Meeting Abstract

    Febres-Aldana, C.; Vanderbilt, C.; Seshan, S.; Richards, A.; Frosina, D.; Jungbluth, A.; Kezlarian, B.; Bodd, F.; Quintanal-Villalonga, A.; Ladanyi, M.; more...
    Laboratory Investigation (2023)

    Fulltext@MSK | Save
  • SRC family kinase inhibition targets YES1 and YAP1 as primary drivers of lung cancer and as mediators of acquired resistance to ALK and epidermal growth factor receptor inhibitors
    Journal Article

    Sato, H.; Kubota, D.; Qiao, H.; Jungbluth, A.; Rekhtman, N.; Schoenfeld, A. J.; Yu, H. A.; Riely, G. J.; Toyooka, S.; Lovly, C. M.; more...
    JCO Precision Oncology (2022)

    Fulltext@MSK | Save
  • POU2F3 in SCLC: Clinicopathologic and genomic analysis with a focus on its diagnostic utility in neuroendocrine-low SCLC
    Journal Article

    Baine, M. K.; Febres-Aldana, C. A.; Chang, J. C.; Jungbluth, A. A.; Sethi, S.; Antonescu, C. R.; Travis, W. D.; Hsieh, M. S.; Roh, M. S.; Homer, R. J.; more...
    Journal of Thoracic Oncology (2022)

    Fulltext@MSK | Save
  • Expression of novel neuroendocrine markers in breast carcinomas: A study of INSM1, ASCL1, and POU2F3
    Journal Article

    Zhong, E.; Pareja, F.; Hanna, M. G.; Jungbluth, A. A.; Rekhtman, N.; Brogi, E.
    Human Pathology (2022)

    Fulltext@MSK | Save
  • Tuft cell master regulator POU2F3 is a novel helpful diagnostic immunohistochemical marker in neuroendocrine-low small cell lung carcinomas
    Meeting Abstract

    Baine, M.; Hsieh, M. S.; Lai, W. C.; Egger, J.; Jungbluth, A.; Sauter, J.; Chang, J.; Buonocore, D.; Travis, W.; Sen, T.; more...
    Modern Pathology (2021)

    Fulltext@MSK | Save
  • Interpretation of methylthioadenosine phosphorylase (MTAP) expression by immunohistochemistry in malignant pleural mesothelioma is improved with monoclonal antibody 1813 compared to monoclonal antibody EPR6893
    Meeting Abstract

    Febres-Aldana, C.; Jungbluth, A.; Adusumilli, P.; Buonocore, D.; Chang, J.; Frosina, D.; Geronimo, J.; Hernandez, E.; Offin, M.; Rekhtman, N.; more...
    Modern Pathology (2021)

    Fulltext@MSK | Save
  • Identification of small cell lung carcinoma subtypes defined by ASCL1, NEUROD1, YAP1 and POU2F3 in cytology specimens
    Meeting Abstract

    Baine, M.; Hsieh, M. S.; Lai, W. C.; Egger, J.; Jungbluth, A.; Wei, X. J.; Rosenblum, M.; Lin, O.; Sauter, J.; Chang, J.; more...
    Modern Pathology (2021)

    Fulltext@MSK | Save
  • Tuft cell master regulator POU2F3 is a novel helpful diagnostic immunohistochemical marker in neuroendocrine-low small cell lung carcinomas
    Meeting Abstract

    Baine, M.; Hsieh, M. S.; Lai, W. C.; Egger, J.; Jungbluth, A.; Sauter, J.; Chang, J.; Buonocore, D.; Travis, W.; Sen, T.; more...
    Laboratory Investigation (2021)

    Fulltext@MSK | Save